Continued progress with stage III colorectal cancer-a triple cohort study

New Zealand Medical Journal

Volumn 126, Issue 1382, 2013, Pages 11-24

  Lim, Michael ^a   Sharma, Prashant ^a   Ing, Andrew ^a   Blackburne, Heidi ^a   Robinson, Bridget ^a   Dixon, Liane ^a   Frampton, Chris ^a   Frizelle, Frank ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADJUVANT CHEMOTHERAPY; AGED; ARTICLE; CANCER STAGING; COHORT ANALYSIS; COLON ADENOCARCINOMA; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DEATH; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; RECTUM CARCINOMA; RETROSPECTIVE STUDY; STOMA; SURGICAL TECHNIQUE; THORAX RADIOGRAPHY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; COLECTOMY; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; HUMANS; KAPLAN-MEIER ESTIMATE; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEW ZEALAND; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84884540860     PISSN: 00288446     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ministry of Health, University of Otago. 2010. The Burden of Cancer: New Zealand 2006. Wellington: Ministry of Health. http://www.health.govt.nz/publication/burden-cancer-newzealand-2006 Accessed May 2012.
2. Ministry of Health. 2010. Cancer Projections: Incidence 2004-08 to 2014-18. Wellington: Ministry of Health. http://www.health.govt.nz/publication/cancer-projections-incidence-2004-08-2014-18 Accessed May 2012.
3. Ministry of Health. Cancer patient survival-change over time update-covering the period 1994 to 2009. Wellington: Ministry of Health. Published March 2012. http://www.health.govt.nz/publication/cancer-patient-survival-change-over-time-updatecovering-period-1994-2009 Accessed May 2012.
4. Jadallah F, McCall JL, van Rij AM. Recurrence and survival after potentially curative surgery for colorectal cancer. N Z Med J. 1999;112:248-50.
5. Semmens JB, Platell C, Threlfall TJ, et al. A population-based study of the incidence, mortality and outcomes in patients following surgery for colorectal cancer in Western Australia. Aust N Z J Surg. 2000;70:11-8.
6. Hoffmann D, Moore J, Roder D. Trends in survival from colonic cancer: the impact of subspecialization. Aust N Z J Surg. 1997;67:842-5.
7. Faivre-Finn C, Bouvier-Benhamiche AM, Phelip JM, et al. Colon cancer in France: evidence for improvement in management and survival. Gut. 2002;51:60-4.
8. Morris E, Haward RA, Gilthorpe MS, et al. The impact of the Calman-Hine report on the processes and outcomes of care for Yorkshire's colorectal cancer patients. Br J Cancer. 2006;95:979-985.
9. Salz T, Sandler RS. The effect of hospital and surgeon volume on outcomes for rectal cancer surgery. Clin Gastroenterol Hepatol. 2008;6:1185-1193.
10. Phang PT, McGahan CE, McGregor G, et al. Effects of change in rectal cancer management on outcomes in British Columbia. Can J Surg. 2010;53:225-231.
11. Bujanda L, Sarasqueta C, Hijona E, et al. Colorectal cancer prognosis twenty years later. World J Gastroenterol. 2010;16:862-867.
12. van Gijn W, van de Velde CJH. 2010 SSO John Wayne Clinical Research Lecture: Rectal Cancer Outcome Improvements in Europe: Population-Based Outcome Registrations will Conquer the World. Ann Surg Oncol. 2011;18:691-696.
13. Dobie SA, Warren JL, Matthews B, et al. survival benefits and trends in use of adjuvant therapy among elderly stage ii and iii rectal cancer patients in the general population. Cancer. 2008;112:789-799.
14. Robinson B, Frizelle F, Dickson M, et al. Colorectal cancer treated at Christchurch Hospital, New Zealand: A comparison of 1993 and 1998 cohorts. NZ Med J. 2005;118:U1323. http://journal.nzma.org.nz/journal/118-1210/1323/content.pdf
15. Maughan NJ, Morris E, Forman D, et al. The validity of the Royal College of Pathologists' colorectal cancer minimum dataset within a population. Br J Cancer. 2007;97:1393-8.
16. McFarlane K, Dixon L, Wakeman CJ, et al. The process and outcomes of a nurse-led colorectal cancer follow-up clinic. Colorectal Dis. 2012;14:245-9.
17. Finan PJ. Smith J. Walker K, et al. The National Bowel Cancer Audit Report (NBOCAP) for 2011. http://www.ic.nhs.uk/webfiles/Services/NCASP/audits%20and%20reports/Bowel_Cancer_Au dit_Report_2011_interactive.pdf Accessed May 2012.
18. Phillips RK, Hittinger R, Blesovsky L, et al. Large bowel cancer: surgical pathology and its relationship to survival. Br J Surg. 1984;71:604-10.
19. Blumberg D, Paty PB, Picon AI, et al. Stage I rectal cancer: identification of high-risk patients. J Am Coll Surg. 1998;186:574-9.
20. Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990;322:352-8.
21. Wolmark N, Rockette H, Fisher B, et al. The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol. 1993:11:1879-87.
22. Wolmark N, Rockette H, Mamounas E, et al. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-04. J Clin Oncol. 1999;17:3553-9.
23. Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med. 2000;28(343):905-14.
24. Kerr DJ, Gray R, McConkey C, et al. Adjuvant chemotherapy with 5-fluorouracil, L-folinic acid and levamisole for patients with colorectal cancer: non-randomised comparison of weekly versus four-weekly schedules-less pain, same gain. QUASAR Colorectal Cancer Study Group. Ann Oncol. 2000;11:947-55.
25. Cunningham D, Pyrhönen S, James RD, et al. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet. 1998;352:1413-8.